D&L PEPTIDES LTD
Significant control: Lee David Jackson (25–50%), Daniel Thomas Matthew Burrell (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for D&L Peptides Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does D&L Peptides Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
D&L PEPTIDES LTD is an active private limited company (company number 16977255) incorporated on 21 January 2026, registered in Birmingham. Its registered activity is research and experimental development on biotechnology (SIC 72110). No accounts have been filed yet; the first accounts are due by 21 October 2027.
There are 2,418 companies in research and experimental development on biotechnology in the UK with filed accounts; the median reports net assets of £1,000 and is 7 years old.
Ownership and control
- Lee David Jackson
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Mr Daniel Thomas Matthew Burrell
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 21 January 2026under 1 yr ago
- First accounts due
- 21 October 2027in 362 days
- Confirmation statement due
- 4 February 2027in 103 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- No Accounts Filed
Financials
No accounts filed yet. The first accounts are due by 21 October 2027; this page updates when they are filed.
Timeline
- First accounts duein 362 days
- Confirmation statement duein 103 days
- Incorporated
Similar companies in Birmingham
- OPENTRANSFORMERS LTDTamworth · inc. Jan 2026
- KINITOS BIO LTDBirmingham · inc. Jan 2026
- AG10 BIO LTDBirmingham · inc. Mar 2026
- ASM R&D LTDBirmingham · inc. Dec 2025
- EQUINOVA THERAPEUTICS LIMITEDSolihull · inc. Dec 2025
- MICA TX LTDBirmingham · inc. Mar 2026
All companies incorporated on 21 January 2026 · in Jan 2026.
Reminders for D&L PEPTIDES LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.